Mental Health Find the latest releases covering all aspects of mental health, including diagnosis, treatment, and long-term care solutions. Get information regarding educational and awareness campaigns, community outreach programs, fundraising efforts, and charity benefit events. Learn about the most recent research studies and clinical trials in the field of mental health. Also included are releases on substance abuse treatment and recovery options and programmes.

Latest

23 Jan, 2020, 00:01 GMT New Clinical Trial Proves Allen Carr's Easyway to Stop Smoking Seminars Are at Least as Effective as the UK's Gold Standard NHS Stop Smoking Service

The largest and most authoritative research trial of its kind has confirmed that Allen Carr's Easyway (ACE) is now a clinically proven, highly...


15 Jan, 2020, 10:00 GMT Visiongain Launches Report Examining the Potential in the $1.6bn Human Microbiome Therapeutics Market

The global human microbiome therapeutics market is estimated to grow at a CAGR of 80.2% in the first half of the forecast period. The global human...


13 Jan, 2020, 10:42 GMT COMPASS Pathways Granted Patent Covering Use of Its Psilocybin Formulation in Addressing Treatment-resistant Depression

COMPASS Pathways, a mental health care company, announced today that it has been granted US Patent No 10,519,175, relating to methods of treating...


06 Jan, 2020, 01:10 GMT Muse® by Interaxon Inc. Just Gave Us a New Reason to Meditate: a Comfy, Brain Sensing Fabric Headband with Day-to-Night Support and All-New Responsive Go-to-Sleep Journeys

Capitalizing on the award-winning neurofeedback developed for both the Original Muse and Muse 2, Muse S allows users to comfortably go from daytime...


16 Dec, 2019, 15:00 GMT Shwaasa Invites Aspiring Yogis for Its Lifechanging Yoga Teacher Training and Retreats in India and Nepal

Shwaasa has delightfully declared its 200-hour yoga teacher training programs and various beneficial yoga retreats at its ashram in Harihar,...


12 Dec, 2019, 08:00 GMT COMPASS Pathways and King's College London Announce Results From Psilocybin Study In Healthy Volunteers

COMPASS Pathways, a mental health care company, has reported that its COMP360 (psilocybin) was well-tolerated when administered to healthy adult...


10 Dec, 2019, 14:00 GMT Prescient Medicine and Erasmus MC Partner to Study Opioid Addiction Risk

Prescient Medicine Holdings, Inc. and the Department of Clinical Chemistry at Erasmus MC (CC-EMC), Rotterdam today announced a partnership for CC-EMC ...


04 Dec, 2019, 22:00 GMT Birmingham and Solihull Mental Health NHS Foundation Trust Chooses Hyland Healthcare's OnBase to Manage Clinical Content Enterprise-Wide

Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT), one of the most complex mental health trusts in the UK, has selected OnBase from ...


04 Dec, 2019, 15:00 GMT Genes make us who we are, says Grawemeyer psychology winner

A behavioral geneticist who found that DNA is the primary force shaping our personalities has won the 2020 University of Louisville Grawemeyer Award...


03 Dec, 2019, 14:37 GMT Accor releases thought-leading white paper on the business of wellness and hospitality

In "It's a Wellness World: The Global Shift Shaking up Our Business", Accor's Emlyn Brown explains how exceptional wellness experiences are good for...


27 Nov, 2019, 14:27 GMT INC: Higher Nut Consumption May Help Prevent Cognitive Decline in the Elderly

A recent INC-funded study, published in Molecular Nutrition & Food Research[1], showed that a high intake of nuts may help protect the elderly from...


27 Nov, 2019, 08:00 GMT Unsafe Working Environments in the IT Industry Risk People's Health

Excessive working hours, forced labor and discrimination are some of the problems that risk workers' health in the IT industry. Achieving a more...


26 Nov, 2019, 15:00 GMT Six Stress Busting Ways to Survive the Season With BioCare

It's the most wonderful time of the year; but dark days, long nights, festive overindulgence, financial strain, family worries and low immunity can...


26 Nov, 2019, 13:44 GMT Patients Turn to CBD in Search of Relief for their Mental Health Disorders

In 2017, it was reported that 3.8% of the global population, or 284 million people, suffered from anxiety disorders, according to Our World in Data....


19 Nov, 2019, 12:00 GMT Alkermes Submits New Drug Application to U.S. Food and Drug Administration for ALKS 3831 for Treatment of Schizophrenia and Bipolar I Disorder

Alkermes plc (Nasdaq: ALKS) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...


13 Nov, 2019, 18:26 GMT Embrace2 by Empatica Used by NEC in Revolutionary Employee Health Study

MIT spin-off and AI pioneers Empatica have partnered with NEC Corporation, the Japanese multinational information and network technology company, to...


13 Nov, 2019, 10:00 GMT No Trust in Government to Handle Drug and Alcohol Fuelled Crime, Survey Conducted by Ocean Recovery Centre

A recent survey conducted by Ocean Recovery Centre regarding common drug and alcohol-related issues has shown that there is very little confidence in ...


12 Nov, 2019, 13:45 GMT Psilocybin Mushrooms Quickly Emerging as Powerful Way to Treat Depression and Addiction

Johns Hopkins Medicine and New York University aren't the only institutions uncovering the benefits of psilocybin mushrooms. According to a study...


12 Nov, 2019, 08:00 GMT EU-Funding: Micreos Awarded €2.5 Million for Breakthrough for Skin Problems Including Acne and Eczema

For its research in the field of antibacterial technology, Dutch biotech Micreos was awarded the highest possible sum of €2.5 million under the EU's...


11 Nov, 2019, 13:30 GMT ATAI Life Sciences and Cyclica launch AI-enabled psychedelics lab to revolutionize drug development for mental health disorders

ATAI Life Sciences AG, a global biotech platform that envisions an end to mental illnesses, and Cyclica Inc., a leading biotechnology company that...


06 Nov, 2019, 09:58 GMT IRLAB's Drug Candidates IRL942 and IRL1009 Have Been Granted Patents in the US and Europe

IRLAB announced today that drug candidates IRL942 and IRL1009 have been granted composition of matter patents in the US and Europe from respective...


03 Nov, 2019, 02:20 GMT Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer's Disease

Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China's National Medical Products Administration (NMPA) has approved...


30 Oct, 2019, 13:00 GMT 8th Annual eCOA Forum Hosted by Signant Health to Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology

Signant Health is proud to host its 8th annual eCOA Forum, which convenes clinical operations and outcomes research leaders for the industry's...


28 Oct, 2019, 12:45 GMT Top Cannabis Companies Getting Involved With Magic Mushrooms to Treat Depression and Addiction

Another drug may soon follow it the footsteps of cannabis -- psilocybin mushrooms. In fact, analysts argue mushrooms may hold untapped medical...


25 Oct, 2019, 16:00 BST This Diwali, CRY Lights up the Lives of India's Disadvantaged Children

rifa (name changed) from northern India's Uttar Pradesh state, is a child-rights activist, whose mission is to create awareness and prevent early...